Cancer treatment in the coronavirus disease pandemic.
Lung Cancer
; 152: 98-103, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-974348
ABSTRACT
Half a year after its emergence, severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has resulted in a pandemic, with cases continuing to increase in nearly every country. Surges in coronavirus disease of 2019 (COVID-19) cases have clearly had profound effects on current cancer treatment paradigms. Considering the effect of antineoplastic treatment and the immunosuppressive properties of cancer itself, cancer patients are deemed to be more vulnerable to SARS-CoV-2. Hence, the specific risk of SARS-CoV-2 must be carefully weighed against the benefit of antineoplastic treatment for cancer patients in the COVID-19 era. In this review, we discuss the current evidence in this important field, and in particular, the effect of SARS-CoV-2 on antineoplastic treatment.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Observational study
/
Prognostic study
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Lung Cancer
Journal subject:
Neoplasms
Year:
2021
Document Type:
Article
Affiliation country:
J.lungcan.2020.12.012
Similar
MEDLINE
...
LILACS
LIS